These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 25730004)
81. [Expression of CYR61, CTGF, VEGF-C, VEGFR-2 mRNA in bone marrow of leukemia patients and its clinical significance]. Xu N; He QT; Lu Y; Han XM; Ma HJ; Zhang DX; Liu XW; Yuan XJ; Jia GR; Li J; Li Z; Li ZQ; Han HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1368-73. PubMed ID: 22169285 [TBL] [Abstract][Full Text] [Related]
82. Evaluation of the antitumor activity of platinum nanoparticles in the treatment of hepatocellular carcinoma induced in rats. Medhat A; Mansour S; El-Sonbaty S; Kandil E; Mahmoud M Tumour Biol; 2017 Jul; 39(7):1010428317717259. PubMed ID: 28720064 [TBL] [Abstract][Full Text] [Related]
83. Anti‑angiogenesis gene therapy for hepatocellular carcinoma via systemic injection of mesenchymal stem cells engineered to secrete soluble Flt‑1. Li G; Miao F; Zhu J; Chen Y Mol Med Rep; 2017 Nov; 16(5):5799-5806. PubMed ID: 28849176 [TBL] [Abstract][Full Text] [Related]
84. The effect of a single anti-Vascular Endothelial Growth Factor injection on neonatal growth and organ development: In-vivo study. Khalili S; Shifrin Y; Pan J; Belik J; Mireskandari K Exp Eye Res; 2018 Apr; 169():54-59. PubMed ID: 29421328 [TBL] [Abstract][Full Text] [Related]
85. Naringin promotes fracture healing through stimulation of angiogenesis by regulating the VEGF/VEGFR-2 signaling pathway in osteoporotic rats. Song N; Zhao Z; Ma X; Sun X; Ma J; Li F; Sun L; Lv J Chem Biol Interact; 2017 Jan; 261():11-17. PubMed ID: 27833010 [TBL] [Abstract][Full Text] [Related]
88. Vascular endothelial growth factor receptor-2 and its association with tumor immune regulatory gene expression in hepatocellular carcinoma. Liu ZL; Zhu LL; Liu JH; Pu ZY; Ruan ZP; Chen J Aging (Albany NY); 2020 Nov; 12(24):25172-25188. PubMed ID: 33223512 [TBL] [Abstract][Full Text] [Related]
89. Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression. Zoheir KM; Abd-Rabou AA; Harisa GI; Ashour AE; Ahmad SF; Attia SM; Bakheet SA; Abdel-Hamied HE; Abd-Allah AR; Kumar A Int J Clin Exp Pathol; 2015; 8(8):8821-31. PubMed ID: 26464624 [TBL] [Abstract][Full Text] [Related]
90. Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study. Aglan HA; Ahmed HH; El-Toumy SA; Mahmoud NS Tumour Biol; 2017 Jun; 39(6):1010428317699127. PubMed ID: 28618930 [TBL] [Abstract][Full Text] [Related]
91. Constructing Tumor Vaccines Targeting for Vascular Endothelial Growth Factor (VEGF) by DNA Shuffling. Bie N; Zhao X; Li Z; Qi G J Immunother; 2016 Sep; 39(7):260-8. PubMed ID: 27428264 [TBL] [Abstract][Full Text] [Related]
92. Identification of VEGFs-related gene signature for predicting microangiogenesis and hepatocellular carcinoma prognosis. Jiang S; Zhu G; Tan Y; Zhou T; Zheng S; Wang F; Lei W; Liu X; Du J; Tian M Aging (Albany NY); 2024 Jun; 16(12):10321-10347. PubMed ID: 38874512 [TBL] [Abstract][Full Text] [Related]
93. Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition. Marwick JA; Stevenson CS; Giddings J; MacNee W; Butler K; Rahman I; Kirkham PA Am J Physiol Lung Cell Mol Physiol; 2006 May; 290(5):L897-908. PubMed ID: 16361360 [TBL] [Abstract][Full Text] [Related]
95. Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma. Ferreira CV; Siqueira DR; Romitti M; Ceolin L; Brasil BA; Meurer L; Capp C; Maia AL Int J Mol Sci; 2014 Mar; 15(4):5323-36. PubMed ID: 24675699 [TBL] [Abstract][Full Text] [Related]
96. Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implication. Bantel H; Canbay A Gut; 2018 Jul; 67(7):1206-1207. PubMed ID: 29353250 [No Abstract] [Full Text] [Related]